Bloomberg Bntx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bloomberg bntx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bloomberg Bntx Today - Breaking & Trending Today
J&J s COVID-19 vaccine could protect millions - if people take it One-dose version s overall efficacy is below Pfizer, Moderna Angelica LaVito and Riley Griffin, Bloomberg March 1, 2021 FacebookTwitterEmail Johnson & Johnson’s Covid-19 vaccine could protect millions more Americans from contracting the coronavirus. The key will be assuring people that the single-shot vaccine is worth taking, as its overall efficacy appears lower than the two-dose ones already on the market in the U.S. J&J’s shot, which U.S. regulators authorized Saturday, is more convenient than the vaccines cleared by the Food and Drug Administration last year. It requires one injection and can be stored for months in a refrigerator. State health officials and the Biden administration see it as a way to quickly host mass clinics as more transmissible virus variants continue to spread. Yet the ease of distributing the vaccine will need to be balanced with the risk of creating the percep ....
Israel gives half of population at least one COVID shot Yaacov Benmeleh, Bloomberg FacebookTwitterEmail Israel has now vaccinated half its population against Covid-19, another milestone on the way to subduing the pandemic. More than 4.6 million people have gotten at least one dose of the vaccine from Pfizer Inc. and BioNTech SE, according to Health Ministry data released Friday. With nearly 8% of the country having recovered from the disease and likely developing some resistance to reinfection, that could bring Israel closer to herd immunity. Vaccinating about 60% to 70% of the population should be enough to rein in infections, illness and death, estimates Raina MacIntyre, a professor of biosecurity at the University of New South Wales, based off the latest data from Israel. ....
COVID-19 vaccines: Pfizer-BioNTech shot likely to foil mutant, new study shows Study on South Africa strain suggests some re-infection threat Naomi Kresge and Janice Kew, Bloomberg Jan. 20, 2021 FacebookTwitterEmail Pfizer Inc. and BioNTech SE built the case that their Covid-19 vaccine will protect against the new variant of the coronavirus that emerged in the U.K. with results of another lab trial. Like previous work out of the University of Texas Medical Branch, the results published on Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize a version of the mutant virus that was created in the lab. The study was published on preprint server BioRxiv prior to peer review. ....
Pfizer, BioNTech shot may defeat new variants, study shows lmtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lmtonline.com Daily Mail and Mail on Sunday newspapers.